Thrivent Financial For Lutherans Atri Cure, Inc. Transaction History

Thrivent Financial For Lutherans

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$35.1 - $66.01 $542,119 - $1.02 Million	-15,445 Closed	0 $0
Q2 2021 Sep 24, 2021	BUY	$64.13 - $80.18 $990,487 - $1.24 Million	15,445 New	15,445 $1.23 Million
Q2 2021 Aug 19, 2021	SELL	$64.13 - $80.18 $990,487 - $1.24 Million	-15,445 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$34.56 - $57.55 $533,779 - $888,859	15,445 New	15,445 $860,000

212

49.7M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.4B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

Stay updated on Thrivent Financial For Lutherans with notifications on news.